Home >> Marketplace Directory >> Multiplex Staph blood culture panel cleared, 5/16

Multiplex Staph blood culture panel cleared, 5/16

image_pdfCreate PDF

 

May 2016—Great Basin Scientific has received FDA clearance for its Staph ID/R Blood Culture Panel. The panel is a sample-to-result, automated, DNA multiplex assay for simultaneous identification of Staphylococcus aureus and Staphylococcus species directly from positive blood cultures. The panel identifies coagulase-negative staphylococci such as S. epidermidis that are part of the normal flora of human skin. The multiplex test also identifies the mecA gene that confers resistance to methicillin and other beta-lactams.

The company said it expects to offer the panel at a significantly lower cost than other molecular blood panels on the market, making fast, easy diagnosis of staph-caused blood sepsis affordable for the small to midsize hospitals that Great Basin serves.

Great Basin Scientific, 801-990-1055

CAP TODAY
X